United States set
language
Menu Shopping cart $0 Search

Interleukin-29 (IL-29, IFN-l1)

Interleukin-29 (IL-29) is a protein of the helical cytokine family and is a type III interferon sharing many functions with the type I family of interferons. The IL-29 gene is found on chromosome 19 in humans. It is also known as IFN-λ1 and is highly similar in amino acid sequence to the IL-28, the other type III interferon. IL-29 does not bind the IFN-α/β receptor, but instead signals through a receptor composed of the IL-28R1 and IL-10R2 subunits. Initial characterizations of the receptor demonstrated that it has a ubiquitous tissue distribution and is expressed on most non-hematopoietic cells. Generation of native IL-29 is achieved by monocytes and dendritic cells in response to viral infection and stimulation with toll-like receptor ligands. IL-29 plays an important role in host defenses against microbes and its gene is highly upregulated in cells infected with viruses. IL-29 has significant antiviral activity and immunoregulatory properties and appears to inhibit T helper-2 (Th2) responses regarding inhibition of IL-13 production, compared with IL-4 or IL-5. The antiviral activities of IL-29 include the upregulation of MHC Class I expression on the cell surface and the expression of PKR. The ligand/receptor complex seems to signal through the Jak-STAT pathway.

1 result found in Immunoassays

Immunoassays
Product Size Price
Interleukin-29 Human ELISA

Type: Sandwich ELISA, Biotin-labelled antibody

RAF062R 96 wells (1 kit) $736
 
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít
Privacy Settings

We, BioVendor Group, use cookies and personal data to ensure the functionality of the website and, with your consent, for personalizing the content of our web pages, among other things. Detailed information about cookies and the transfer of personal data based on consent can be found in the More Information section. You can adjust the scope of allowed cookies and granted consents in the Settings section.